CERIDIAN HCM HOLDING INC.

(CDAY)
  Report
Delayed Nyse  -  05/23 04:00:02 pm EDT
56.09 USD   -0.90%
12:06pJefferies Adjusts Ceridian HCM Holding's Price Target to $56 from $65, Keeps Hold Rating
MT
05/09Mizuho Securities Lowers Ceridian HCM Holding's Price Target to $80 From $100, Buy Rating Kept
MT
05/05Deutsche Bank Adjusts Ceridian HCM Holding Price Target to $85 From $105, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 9 77315 75015 8088 640--
Enterprise Value (EV)1 10 16916 22916 5739 4669 3948 640
P/E ratio 128x-3 552x-209x-143x-708x202x
Yield ------
Capitalization / Revenue 11,9x18,7x15,4x7,09x6,05x5,15x
EV / Revenue 12,3x19,3x16,2x7,77x6,58x5,15x
EV / EBITDA 55,1x102x102x47,6x37,6x27,0x
Price to Book 5,21x7,55x7,13x4,02x4,06x-
Nbr of stocks (in thousands) 143 978147 803151 331152 645--
Reference price (USD) 67,910710456,656,656,6
Announcement Date 02/05/202002/09/202102/09/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 8248431 0241 2191 4281 678
EBITDA1 185159163199250320
Operating profit (EBIT)1 13311186,7128165210
Operating Margin 16,1%13,2%8,47%10,5%11,5%12,5%
Pre-Tax Profit (EBT)1 34,3-20,0-90,3-79,9-33,355,7
Net income1 78,7-4,00-75,4-66,9-9,6116,8
Net margin 9,55%-0,47%-7,36%-5,49%-0,67%1,00%
EPS2 0,53-0,03-0,50-0,40-0,080,28
Dividend per Share2 ------
Announcement Date 02/05/202002/09/202102/09/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 257282293294302328
EBITDA1 39,438,757,445,146,549,3
Operating profit (EBIT)1 18,918,844,428,227,429,2
Operating Margin 7,35%6,66%15,1%9,57%9,05%8,89%
Pre-Tax Profit (EBT)1 -29,4-10,5-24,4-24,1-22,6-15,1
Net income1 -20,9-9,50-27,4-16,3-12,6-9,77
Net margin -8,13%-3,37%-9,34%-5,53%-4,15%-2,98%
EPS2 -0,14-0,06-0,18-0,09-0,08-0,06
Dividend per Share ------
Announcement Date 11/03/202102/09/202205/04/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 396480765826755-
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,14x3,02x4,71x4,16x3,02x-
Free Cash Flow1 34,3-48,337,374,1113110
ROE (Net Profit / Equities) 4,50%3,67%1,87%0,27%1,78%1,60%
Shareholders' equity1 1 749-109-4 037-24 351-5411 047
ROA (Net Profit / Asset) 1,39%1,14%0,58%-0,95%-0,35%0,50%
Assets1 5 667-350-12 9407 0322 7393 350
Book Value Per Share2 13,014,114,714,113,9-
Cash Flow per Share2 0,34-0,210,320,721,011,66
Capex1 16,318,111,511,914,414,4
Capex / Sales 1,98%2,15%1,12%0,97%1,01%0,86%
Announcement Date 02/05/202002/09/202102/09/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 8 639 697 434
Net sales (USD) 1 024 200 000
Number of employees 7 462
Sales / Employee (USD) 137 255
Free-Float 99,0%
Free-Float capitalization (USD) 8 555 409 450
Avg. Exchange 20 sessions (USD) 134 460 807
Average Daily Capital Traded 1,56%
EPS & Dividend
Change in Enterprise Value/EBITDA